Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT05556356
Eligibility Criteria:
Inclusion Criteria:
* Adults (18 years of age or older)
* Patients presenting with symptomatic 1st CMC arthritis with or without scaphotrapeziotrapezoid arthritis
* Eaton Classification stage II, III, or IV OA of the first CMC joint based on xrays
* Patients who plan to undergo a ligament reconstruction and tendon interposition (LRTI) or thumb suspensionplasty procedure within 6 months of enrolling to study
* Bilateral thumbs included
Exclusion Criteria:
* \<18 years age
* Prior surgical history of ipsilateral 1st CMC arthroplasty or procedures involving thumb CMC joints
* Prior ipsilateral tendon rupture or ipsilateral peripheral nerve palsy
* History of opioid dependency or current chronic opioid use
* Contraindication to acetaminophen use
* Contraindication to NSAID use
* Contraindication or known allergy to peripheral nerve blockade, including coagulopathy
* Contraindication to supraclavicular block due to anatomic variability or inability to tolerate phrenic nerve blockade.
* Contraindication to multivitamin use
* Liver dysfunction
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05556356
Study Brief:
Protocol Section:
NCT05556356